Objective: was to take stock of the screening and treatment of precancerous and cancerous lesions of the cervix in the health district of commune V of Bamako in Mali. Patients and Methods: This was a descriptive, cross-sectional, analytical study with retrospectiveand prospective data collection over a period of 08 years from 1 January 2010 to 31 December 2017. Results: From January 1, 2010 to December 31, 2017, 42492 women were screened on a target of 174777 women, a frequency of 24.30%. The median age of women screened was 32 years; 25% were under 25 years of age. A similar proportion were over the age of 40. 3/4 of the women screened belonged to the age group of 20 to 49 years. Women aged 55 and over were the least represented by 5.7%. Screening coverage was over 35% among the 25-49 age groups. It was 31.9% and 23.1% among women aged 50 – 54 and 55 – 59 respectively. Screening coverage was less than 15% among 60-year-olds and older. Of the 22842 women screened, 90.1% had a normal cervix at IVA/IVL. However 4.1% cervix positivity to acetic acid and 5.1% positivity to Lugol. 0.7% of the women screened had clinically cancerous lesions. At the anatomo-pathological level, various histological lesions have been observed with regard to precancerous lesions, squamous cell carcinoma and adenocarcinomas. Indeed, among the women screened 96.5% had a normal cervix with benign lesions. For those with pathological histological results, 2.6% of them had histology with precancerous le sions and 0.8% had squamous cell carcinomas. A low rate of 0.1% of adenocarcinoma was recorded in our series. Conclusion: The improvement of screening indicators with IVA/IVL which does not require large resources is a promising avenue in Africa on which, it can hope for the rate of morbidity and mortality by cervical cancer.